Mediastinal lymphoma in cats with feline leukemia carries a poor prognosis,
with an average survival time of 3 months.
With treatment, in dogs that feel well, about 80 % — 90 % of dogs with lymphoma attain a complete remission
with an average survival of 12 - 14 months.
As previously reported, IFN - γ blockade led to significant improvement in survival in unimmunized mice, but surprisingly in gp33 - immunized mice, IFN - γ — blocked mice continued to have significant mortality,
with an average survival of 15 d postinfection, similar to control mice without IFN - γ blockade (Fig. 3A).
Adult patients with ALL are more likely to relapse, and their outcomes are typically poor,
with an average survival of roughly 40 %.
Glioblastoma is the most common and the most aggressive form of brain cancer in adults,
with average survival after diagnosis of around 15 months.
Not exact matches
Because the
average life expectancy of males, females, and married couples is 82, 85, and 89, respectively, and the probability that one member of a married couple will live to age 95 is 18 percent for the
average American, it is reasonable to anticipate that replacing static retirement periods
with survival probabilities will provide evidence of even greater consumption gaps (Centers for Disease Control and Prevention 2010).
The combination therapy increased the
average survival to 37 days,
with four of the mice living more than 120 days.
With a three - year
survival rate of 94.39 percent for all adult kidney recipients — above the 92.62 percent national
average — UCSF has more patients on the kidney transplant waiting list than any other U.S. transplant center.
At 10 years after transplantation, the organs from donors
with unacceptable / high risk provided each recipient
with more than 7 additional years of
survival on
average.
Glioblastoma is the most aggressive type of tumor that originates in the brain and
with no curative treatments currently available, the
average survival time for patients ranges from 15 to 18 months.
Even
with more beetles munching on them, an increase of 2 °C — the current target cap for global warming — bumps the
average mosquito's probability of
survival into adulthood by 53 %.
Usually, treatment would require whole - brain radiation which is extremely toxic and the
average survival time is just 3 - 6 months from diagnosis,
with fewer than 20 per cent of patients surviving more than one year.
These same patients also had significantly longer
average survival times (36 months) compared to patients
with high ERCC1 levels (10 months).
Similarly, 29 patients had low TS levels and significantly longer
average survival times (36 months) than patients
with high TS levels (15 months).
If that climate scenario is combined
with habitat restoration efforts, particularly those aimed at connecting habitats that have been fragmented by human activity, the
average population has a much higher probability of
survival — about 50 %.
More than 11,880 new cases of GBM were estimated to occur in 2015,
with overall
survival averaging 12 to 15 months, so there is an urgent need for more effective therapies.
Among patients
with metastatic melanomas
with the worst prognosis (stage M1c), the
average progression - free
survival times were 8.5 months for the combination treatment, 5.4 months for nivolumab alone and 2.8 months for ipilimumab alone.
Patients who were administered ipilimumab survived longer without experiencing melanoma recurrence,
with an
average recurrence - free
survival of 26.1 months in ipilimumab treated patients and 17.1 months in placebo treated patients.
Solid line (
with triangles in panel A and squares in panel B):
Average female
survival probability at simulation end.
THE virus that helped eradicate smallpox is now working its magic on liver cancer, trebling the
average survival time of some people
with the disease.
To treat chronic liver disease, the cells would have to be stable for at least five years, the
average survival period for those
with the disease.
When the researchers looked at progression - free
survival times among patients
with and without the V600 type of mutation of the BRAF gene, the
average for patients taking both drugs without the mutation was 11.2 months, and it was 11.7 months for those
with the mutation.
Importantly, these mice still had significant improvement in
survival compared
with immunized mice receiving placebo treatment (
average survival 9 d), indicating that IFN - γ continues to play an important role in mortality in enhanced HLH disease.
The
average progression - free
survival — the time from randomization to the first evidence of metastasis — was 40.5 months for participants receiving apalutamide, compared
with 16.2 months for those taking a placebo.
Given that the
average 1 - year
survival rate of patients
with metastatic melanoma is less than 25 %, this represents a nearly triple-fold improvement.
There was a telling quote from Michael Davies, MD, of the center's Melanoma Medical Oncology Department: «The
average survival for patients
with stage 4 metastatic melanoma is 6 to 10 months, and this hasn't changed for 30 years.»
The
average progression - free
survival of certain women given Zejula was 21 months, compared
with 5.5 months among women who took a placebo, the FDA said.
Cats
with lymphoma who are not treated
with chemotherapy have an
average survival time of 4 weeks once the diagnosis has been made.
The
average hospital stay for treating parvo is five to seven days long, and the
survival rate
with proper treatment is 70 to 80 percent, according to About.com.
On
average,
survival for cats
with HCM and heart failure is 12 to 18 months after diagnosis.
The median («
average»)
survival in 55 dogs treated
with surgery alone (before drugs that could help were identified) was 109 days.
The median («
average»)
survival of the dogs treated
with piroxicam was 244 days.
The
average survival time for a dog
with Cushing's disease is about two years, but this statistic does not mean that Cushing's causes death.
These cats show an
average survival time of 9 - 12 months,
with the initial response to treatment often giving an indication of
survival time.
Unfortunately, the
average survival time even
with treatment is only one year, and most dogs succumb to the disease within two years.
One study shows the
average survival time of dogs
with enlarged heart is anywhere from 6 months to 12 months,
with very few cases where a dog survives 1.5 years (source).
For those dogs that have the most common type (external lymph nodes enlargement), the
average remission time is usually around 8 - 10 months
with an overall
survival time of about 1 year.
If you know someone who is fighting the dreaded proliferation of abnormal cells (that's what cancer is) you should do careful research, starting
with the knowledge that the
average cost to treat a cancer patient was $ 670,000 in 2011 and
survival rates had not improved.
The
average survival prognosis for patients
with spleen HSA following surgery alone is approximately two months,
with only 10 %
survival at one year.
The
average survival time
with chemotherapy is 3.5 months for virus positive cats and 5 months for non-viral infected cats.
While combination therapy
survival rates
average around one year, approximately 20 % of dogs survive more than two years
with currently available treatments.
The
average survival for dogs
with spleen HSA treated
with surgery and chemotherapy is improved at six to eight months and patients typically experience an excellent QoL during
with treatment.
Another study showed an
average survival time of 391 days, for dogs
with tumors located in a joint.
The
average survival in dogs
with axial osteosarcomas is 4 - 5 months, and the most common cause of treatment failure is local tumor recurrence.
However, dogs
with recurrence had
average survival times of only 28 days post-surgery.
With standard of care treatment, B cell lymphomas with treatment may have an average survival of 9 - 12 months and those with T cell lymphomas may have an average survival of 6 - 9 mon
With standard of care treatment, B cell lymphomas
with treatment may have an average survival of 9 - 12 months and those with T cell lymphomas may have an average survival of 6 - 9 mon
with treatment may have an
average survival of 9 - 12 months and those
with T cell lymphomas may have an average survival of 6 - 9 mon
with T cell lymphomas may have an
average survival of 6 - 9 months.
Well, it's a Battle Royale - inspired multiplayer
survival shooter
with average graphics.
The game's latest update 2.4.2 introduced a Valentine - themed crossbow into the
survival game's mix of weapons, equipped
with infinite arrows that are stealthier than your
average bullet.
Despite a strong premise, our experience
with the early access version was largely full of below -
average survival mechanics.
Specimens of elkhorn coral living in water
with excess carbon dioxide have been studied for fertilization rates, ability of larvae to settle on reef substrate (where they produce new corals), and subsequent growth and
survival.3 Three levels of carbon dioxide were tested, corresponding to concentrations today, at mid-century, and at the end of the century on a high - emissions path.3, 5 At the mid-century concentration, the ability of fertilization to occur and for larvae to settle successfully on the reef was significantly reduced: around 52 percent, and the decline intensified to about 73 percent at the late - century concentration.3 The corals» ability to survive over the long run declined as well, by an
average of 39 percent and 50 percent respectively.3, 4